Jury: Risperdal marketing campaign misled physicians

Share this content:
A jury in South Carolina found Johnson & Johnson's pharmaceutical unit, Ortho-McNeil-Janssen, guilty of misleading doctors about the safety and effectiveness of the anti-psychotic drug Risperdal. Janssen violated South Carolina's consumer protection laws in 2003 when it sent a letter to roughly 7,200 doctors in the state touting the safety and effectiveness of Risperdal, the jury decided. Civil penalties could total more than $35 million, or $5,000 for each letter Janssen sent. That hearing is scheduled to take place April 18-19.